What is NDC 59630-711?

59630-711 is the product NDC for Xocova (ensitrelvir), Ensitrelvir 125 mg/1 tablet, listed with the FDA by Shionogi Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Shionogi Inc., NDC labeler code 59630. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Xocova?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Xocova NDC 59630-711 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59630-711Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59630-0711Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59630-711-07	59630071107	1 BLISTER PACK in 1 CARTON (59630-711-07) / 7 TABLET in 1 BLISTER PACKMarketed from Jul 2, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Xocova
Generic name (nonproprietary): ensitrelvir
Active ingredients: Ensitrelvir — 125 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Shionogi Inc.NDC labeler code 59630
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 220442
Marketing start: Jul 2, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 59630-711_96185ce1-2b27-43a1-9b24-e76cbc91a235SPL ID 96185ce1-2b27-43a1-9b24-e76cbc91a235SPL set ID 526acf60-abc3-2cc2-e063-6294a90affa6RxCUI 2745993, 2745999, 2746000, 2746001UNII PX665RAA3H

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459630071107 followed by a unit qualifier and the quantity

Package 59630-0711-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 3, 2026.

Indications (excerpt from the label)

XOCOVA is indicated for post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19. XOCOVA, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M pro : also referred to as 3CL pro or nsp5 protease) inhibitor, is indicated for post-exposure prophylaxis of coronavirus disease 2019 (COVID‑19) in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59630-711

What is NDC 59630-711?: 59630-711 is the product NDC for Xocova (ensitrelvir), Ensitrelvir 125 mg/1 tablet, listed with the FDA by Shionogi Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Xocova (Ensitrelvir).
What is the active ingredient?: Ensitrelvir.
Who is the labeler?: Shionogi Inc., NDC labeler code 59630. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Xocova?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Xocova (Ensitrelvir) NDC 59630-711